Development Team:

Dr. Jennifer Skelly, McMaster University
Dr. Tazim Virani, Tazim Virani & Associates
Dr. Donna Fedorkow, McMaster University
Dr. Dawn Stacey, University of Ottawa
Dr. Irmajean Bajnok, RNAO

Ms. Rishma Nazarali, RNAO
Ms. Angela Joyce, RNAO
Ms. Yasmin Parpio, McMaster University
Dr. Simone Kaptein, Echo: Improving Women's Health in Ontario

Development Process:

A two phase process was used:

Phase 1: Needs Assessment Phase – Interviews were held with women who had the experience of incontinence and had accessed support from health care professionals; and, interviews with health care providers who specialize in the area of incontinence.

Phase 2: Pilot Test/Feedback Phase – Draft decision guide was reviewed by a group of 25 Nurse Continence Advisors in Ontario. Feedback was gathered through a structured survey. Additionally, the draft decision was reviewed by 13 women with or without experience of incontinence. Feedback was gathered through a similar structured survey.

Format is based on the Ottawa Personal Decision Guide © 2000 A O'Connor, D Stacey, University of Ottawa Canada. Publication Date 2012: Last reviewed March 31, 2012.

References

  • Adapted from existing patient education from Healthwise at www.healthwiseonline.com, Mayo Clinic at www.mayoclinic.com and The Simons Foundation at www.thesimonsfoundation.ca.
  • Adapted from Wagner, T.H., Bavendam, P.D.L., Martin, M.L., & Bueshing, D.P. 1996). Quality of life of persons with urinary incontinence: development of a new measure. Urology, 47(1), 67.71.
  • National Collaborating Centre for Women's and Children's Health (2006). Urinary incontinence: the management of urinary incontinence in women. London, UK: Royal College of Obstetricians and Gynaecologists.
  • National Collaborating Centre for Women's and Children's Health (2006).
  • Wing, R. R., West, d. S., Grady, D., Creasman, J. M., Richter, H. E., Myers, D., Subak, L. L.(2010). Effect of weight loss on urinary incontinence in overweight and obese women: Results at 12 and 18 months. Journal of Urology, 184(3), 1005-10.
  • Weight loss to treat urinary incontinence in overweight and obese women. (5), 481–90.
  • National Collaborating Centre for Women's and Children's Health (2006).
  • Registered Nurses' Association of Ontario (2011). Promoting Continence Using Prompted Voiding. Toronto, On: Registered Nurses' Association of Ontario.
  • Fader, M., Cottenden, A. M., Getliffe, K. (2007). Absorbent products for light urinary incontinence in women. Cochrane Database of Systematic Reviews, 2: CD001406. DOI: 10.1002/14651858.CD001406.pub2.
  • Herbison, G. P., Dean, N. (2002). Weighted vaginal cones for urinary incontinence. Cochrane Database of Systematic Reviews,1.: CD002114. DOI: 10.1002/14651858.CD002114.
  • Dumoulin, C. Hay-Smith, E. J., (2006). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews, (1): CD005654. DOI:10.1002/14651858.CD005654.pub2.
  • Herderschee, R., Hay-Smith, E. J. C., Herbison, G.P., Roovers, J. P., Heineman, M. J. (2011). Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews, 7: CD009252. DOI:10.1002/14651858.CD009252.
  • Lipp, A., Shaw, C., Glavind, K. (2011). Mechanical devices for urinary incontinence in women. Cochrane Database of Systematic Reviews, 7: CD001756. DOI: 10.1002/14651858.CD001756.pub5.
  • Nabi, G., Cody, J. D., Ellis, G., Hay-Smith, J., Herbison, G. P. (2006). Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 4. CD003781. DOI: 10.1002/14651858.CD003781.pub2.
  • Cody, J. D., Richardson, K., Moehrer, B., Hextall, A., Glazener, C. M. A. (2009). Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews, 4. CD001405. DOI:10.1002/14651858.CD001405.pub2.
  • Glazener, C. M. & Cooper, K. ( 2004). Bladder neck needle suspension for urinary incontinence in women. Cochrane Database of Systematic Reviews 2004, 2. CD003636. DOI: 10.1002/14651858.CD003636.pub2.
  • Cornu, J-N., Sebe, P., Pevrat, L., Ciofu, C., Cussenot, O., Haab, F. (2010). Midterm prospective evaluation of TVT-secur reveals high failure rate. European Urology, 58(1), 157-161.
  • Dean, N., Ellis, G., Herbison, G. P., & Wilson, D. (2006). Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews, 3. CD002239. DOI: 10.1002/14651858.CD002239.pub2.
  • Adapted from The SURE Test © O'Connor & Légaré (2008)